Myriad Genetics Inc (MYGN)
18.59
+0.10
(+0.54%)
USD |
NASDAQ |
Apr 23, 16:00
18.59
0.00 (0.00%)
After-Hours: 18:38
Myriad Genetics Cash from Financing (TTM): 152.90M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 152.90M |
| September 30, 2023 | 28.90M |
| June 30, 2023 | 27.80M |
| March 31, 2023 | -8.10M |
| December 31, 2022 | -8.00M |
| September 30, 2022 | -7.00M |
| June 30, 2022 | -77.90M |
| March 31, 2022 | -106.90M |
| December 31, 2021 | -150.60M |
| September 30, 2021 | -153.40M |
| June 30, 2021 | -77.90M |
| March 31, 2021 | -51.20M |
| September 30, 2020 | -1.60M |
| June 30, 2020 | -10.00M |
| March 31, 2020 | -38.80M |
| December 31, 2019 | -48.40M |
| September 30, 2019 | -82.10M |
| June 30, 2019 | 182.30M |
| March 31, 2019 | 168.80M |
| December 31, 2018 | 173.90M |
| September 30, 2018 | 180.40M |
| June 30, 2018 | -95.00M |
| March 31, 2018 | -117.00M |
| December 31, 2017 | -149.40M |
| September 30, 2017 | -127.30M |
| Date | Value |
|---|---|
| June 30, 2017 | 71.80M |
| March 31, 2017 | 88.80M |
| December 31, 2016 | 81.50M |
| September 30, 2016 | 122.70M |
| June 30, 2016 | -68.30M |
| March 31, 2016 | -62.20M |
| December 31, 2015 | -74.20M |
| September 30, 2015 | -163.70M |
| June 30, 2015 | -177.30M |
| March 31, 2015 | -179.15M |
| December 31, 2014 | -119.73M |
| September 30, 2014 | -139.09M |
| June 30, 2014 | -211.80M |
| March 31, 2014 | -156.42M |
| December 31, 2013 | -201.41M |
| September 30, 2013 | -144.99M |
| June 30, 2013 | -80.60M |
| March 31, 2013 | -145.96M |
| December 31, 2012 | -105.31M |
| September 30, 2012 | -87.07M |
| June 30, 2012 | -69.24M |
| March 31, 2012 | -7.348M |
| December 31, 2011 | -77.23M |
| September 30, 2011 | -120.39M |
| June 30, 2011 | -116.60M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-153.40M
Minimum
Sep 2021
182.30M
Maximum
Jun 2019
-23.89M
Average
-24.40M
Median
Cash from Financing (TTM) Benchmarks
| Stryker Corp | -1.594B |
| Haemonetics Corp | 100.06M |
| Perspective Therapeutics Inc | 0.785M |
| Electromed Inc | -0.128M |
| Xtant Medical Holdings Inc | 19.69M |